Irene Y Cheung

5PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2025
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.

Brian H Kushner, Shakeel Modak, Audrey Mauguen

|Jun 27, 2024
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.

Irene Y Cheung, Audrey Mauguen, Shakeel Modak

|Jan 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.

Barbara Spitzer, Kayleigh D Rutherford, Gunes Gundem

|Oct 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.

Shakeel Modak, Pat Zanzonico, Milan Grkovski

|Sep 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.

Shakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung

Pageof 1

Frequent Collaborators

5 joint publications

Nai-Kong V Cheung

2 joint publications

Ellen M Basu

1 joint publications

Milan Grkovski

1 joint publications

Emily K Slotkin